Australia Daily Briefing

Swedish asset manager EQT AB has returned with an improved takeover bid for Perpetual Limited at $22.07 per share — a sweetened offer after Perpetual shareholders pushed back on the original terms. The deal would extract Perpetual's asset management business from its corporate trust operations, a separation the market has been demanding for years. For ASX investors, this is the most significant local M&A catalyst of the week: if EQT closes the deal at these levels, it validates Australian asset manager valuations broadly and signals that European capital is still willing to pay a premium for high-quality Australasian distribution networks.

Analysts are flagging a 33% upside scenario for Evolution Mining shares based on gold's sustained run above key technical levels and the company's operational leverage to the spot price. Gold proxy Newmont (NEM +0.49%) and the broader Mining +0.73% today validated the commodity bid. The Australia-specific angle is that Evolution carries lower sovereign risk than many gold majors, with assets in Queensland and Western Australia operating under stable regulatory frameworks — an attribute worth paying up for when geopolitical risk in EM is elevated (Iran crisis, US-China tariff cycle).

Sigma Healthcare, the ASX-listed company that merged with Chemist Warehouse, is attracting buy-side attention for three structural reasons: brand loyalty in pharmacy retail, expanding private-label margin, and the post-merger cost synergies yet to fully flow through. Healthcare +1.70% today reflects broader sector momentum, but Chemist Warehouse's consumer-facing pharmacy model is a specific domestic growth story that doesn't depend on RBA rate cuts or China demand — two uncertainties that cloud the rest of the index.